– Merck betting $100 million on new China-based pharmaceutical factory (Natural News, Nov 27, 2013):
A recent Reuters article covered Merck’s plan to invest $108 million for a pharmaceutical manufacturing plant to be up and running in China by 2017. This announcement is motivated partly by the anticipation of China’s annual sick-care spending to soar into the 1 trillion dollar range from 2011’s 357 billion dollar expense.
The other motivation is to ensure that Merck can get friendlier with the Chinese government, which thus far has not be as welcoming as most other affluent nations, especially in the land of the medically un-free United States.
There have been investigations by Chinese officials into the “business as usual” policies of international pharmaceutical companies that are tolerated in the USA. One such activity is bribing MDs and health administration officials, a large part of any drug company’s annual promotional and advertising expenses.
So far, Chinese officials have hit GlaxoSmithKline (GSK) the hardest. GSK is under investigation for funneling just under a half-billion dollars through travel agencies in order to bribe doctors and government officials. GSK has lost 61% of its China drug sales with this scandal.
Other international drug companies that do business in China are also being questioned. Sanofi lowered its 2013 profit guidelines based on China’s recent plunging sales. According to Reuters, many Chinese MDs are refusing to see drug company representatives (drug peddlers) to avoid getting snared in the Chinese government’s dragnet on drug company corruption.
Apparently, building a plant in China is a strategy for getting on friendlier terms with Chinese officials, who convict and even execute upper level executives in the food and drug industry for poisoning its citizens. Watch your step Merck execs!
Beneath the friendly faces of pharmaceutical manufacturers
The Reuters article portrays Merck and other drug companies as mostly helpful, though a bit dicey with their marketing techniques. One statement has a quote from a Merck official claiming that they need to be in China to help handle their surge of diabetes and thyroid and heart diseases. How altruistic, NOT!
They simply see the dollar signs from a burgeoning, affluent society that has increasingly turned its back on its own traditional Chinese medicine to get those quick fixes promoted by Western medicine. Perhaps it’s a demand of their increasingly busier lives.
The godfathers who run the Medical Mafia are in and of the pharmaceutical industry. If not actually a functioning part of it, then they rush through government agency revolving doors to further corrupt those groups in Big Pharma’s financial favor.
And the revolving door spins both ways, welcoming former CDC, FDA and other cooperative officials into high level, lucrative positions with Big Pharma companies. For example, the former CDC director and queen of vaccine and swine flu disinformation, Julie Gerberding, has been director of Merck’s vaccine unit since 2010.
Drug companies create hit lists against doctors and writers who investigate their products unfavorably. An Australian attorney representing a Vioxx class action suit against Merck read their interoffice memos in the courtroom: “We may need to seek them out and destroy them where they live.” The memos also mentioned “neutralizing or discrediting” those who spoke out against them.
Merck manufactured Vioxx and kept it on the market even as the death toll from it mounted. And they are the principal source of the MMR vaccine, which is ranked second among the most dangerous vaccines, their toxic “solution” for minor diseases, measles, mumps and rubella.
Merck also manufactures the highly hazardous and unnecessary HPV vaccine Gardasil. As teenage girls and young women drop dead or are permanently disabled from HPV vaccinations, Merck continues lobbying various state governments to create favorable legislation for enforcing inoculations among students.
Merck’s history and intentions are murky at best.
Sources for this article include: